Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Institute of Hematology and Blood Transfusion, Czech Republic
Children's Hospital of Philadelphia
Beth Israel Deaconess Medical Center
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital with Nanjing Medical University
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Taiho Oncology, Inc.
M.D. Anderson Cancer Center
Changhai Hospital
University Hospital, Brest
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Takeda
Disc Medicine, Inc
Zhejiang Cancer Hospital
Ossium Health, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Nice
Memorial Sloan Kettering Cancer Center
University of Vermont
Apollo Therapeutics Ltd
Quercis Pharma AG
Wake Forest University Health Sciences
University of Vermont Medical Center
First Affiliated Hospital of Zhejiang University
Cullgen (Shanghai),Inc
Qilu Pharmaceutical Co., Ltd.
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Grit Biotechnology
Medical University of Gdansk
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Ottawa Hospital Research Institute
Memorial Sloan Kettering Cancer Center
Peter MacCallum Cancer Centre, Australia
Affiliated Hospital of Nantong University
H. Lee Moffitt Cancer Center and Research Institute
ARCE Therapeutics, Inc.
Children's Hospital of Philadelphia
Washington University School of Medicine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University